Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer

Near-Infrared Light Treatment for A Rare Form Of Lung Cancer

Posted on June 22, 2020

Warning: Undefined array key "https://lungcancersymptomsx.com/the-lung-cancer.html" in /home/atozdwxp/lungcancersymptomsx.com/wp-content/plugins/wpa-seo-auto-linker/wpa-seo-auto-linker.php on line 192
Post Views: 638

Lung CancerNagoya University oncologist Kazuhide Sato and team have tested the treatment for a rare type of malignant lung cancer and published its findings in the journal Cells. The team has worked to investigate the effectiveness of near-infrared photoimmunotherapy (NIR-PIT) as a treatment strategy for Malignant Pleural Mesothelioma (MPM). MPM is a rare type of lung cancer that affects the lining of the lungs. Though it rarely spreads to other parts of the body, but as is usually diagnosed at a later stage; this results in poor prognosis. This also leads to limited availability of treatment options.

For NIR-PIT to work, a cancer-targeting compound made of an antibody is first injected. This compound targets a specific structure on the cancer cells and a photoabsorber. When the near-infrared light is shone on the cancer affected area, the compound works to aggregate on the cell membranes. This, in turn, leads to acute cell rupture and tumor death. Kazuhide Sato says, “The lungs and chest cavity contain a large amount of air and are thus very good at effectively transmitting near-infrared light.” “NIR-PIT is a safe phototherapy option that can target a region of interest. The antibody-IR700 conjugate is also non-toxic to the body in the absence of near-infrared light irradiation. We thus thought that NIR-PIT could be an effective strategy for controlling localized MPM,” he added.

The team focused their attention on antibody called NZ-1, which targets a specific part of transmembrane glycoprotein called podoplanin. Podoplanin is generally found on many cell types in body but is particularly abundant in some types of cancer cells like MPM. Sato and his colleagues said that further studies are required to find out ways to ensure that the lung cancer treatment will not kill healthy podoplanin-positive cells.

The information shared in this blog is for educational purposes only.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d